United States - July 3, 2024 — The Oligonucleotide Therapeutics Society (OTS) Annual Meeting provides a forum for engaging cross-disciplinary scientific exchange that sets the stage for groundbreaking new ideas. A diverse group of people, from leading experts in academia and industry to students and health authorities, come together to share advances and create synergy found through uniting the global community. Attendees of the Oligo Meeting will gain an incredible opportunity for learning, collaboration, and networking, with ten sessions plus posters, 750 participants, and more than 25 countries and 350 organizations represented. The topics and sessions have been thoughtfully crafted by an Organizing Committee comprised of authorities in their fields to create an engaging, inspiring experience rich with in-depth information. 

Related

---